Health
Coronavirus vaccine by AstraZeneca begins late-stage US study – 7NEWS.com.au
The company enlisted by Australia as its primary hope for a vaccine has announced a promising step.
AstraZeneca has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate.
Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said on Monday.
Should the trials prove successful, Australians may be in line to receive the AstraZeneca vaccine.
The trial is being conducted under the US governments Operation Warp Speed program.
The program aims to acc…
-
General19 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General15 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General14 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News22 hours agoNew Year’s Eve Events Near Brisbane